National health justice organization Community Catalyst — a steering committee member of the Protecting Immigrant Families Coalition — issued the following statement in response to the Department of Homeland Security's (DHS) changes to "public charge," which will roll back existing...
As consumer interest in non-prescription GLP-1 support continues in 2026, this Alka Lean Supplement Facts review examines the brand-stated chicory root inulin, resistant starch, and probiotic blend, compares the labeled dosages with published ingredient research, and explains the current pricing and guarantee terms buyers should verify before ordering.
EMERYVILLE, Calif., July 18, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced positive 2-year data from the PRISM Phase 2b clinical trial evaluating 4D-150 in a broad wet age-related macular degeneration (wet AMD) population. The data were presented by Carl Awh, M.D., FASRS, Tennessee Retina, in an oral presentation titled “2-Year Follow Up: PRISM Phase 2b Clinical Trial Evaluating Investigational 4D-150, an Intravitreal Gene Therapy, in a Broad Neovascular AMD Population” at the 44 th Annual Scientific Meeting of the American Society of Retina Spe
One-time gene therapy treatment with sura-vec demonstrated long-term efficacy at similar doses to those being evaluated in ongoing late-stage studies: Stable to improved vision through 5 years in wet AMD patients who required frequent anti-VEGF injections prior to one-time sura-vec; no...
NEW YORK, July 18, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AeroVironment, Inc. (NASDAQ: AVAV) between June 25, 2025 and March 10, 2026, inclusive (the "Class Period"), of the important July 27, 2026 lead plaintiff...
— Le commutateur magnétique TMR de nouvelle génération, avec un courant d'alimentation maximal ultra-faible de 50 nA, vient élargir la gamme éprouvée de capteurs CGM de MDT ZHANGJIAGANG, Chine, 18 juillet 2026 /PRNewswire/ -- MultiDimension Technology Co., Ltd. (MDT), l'un des principaux...
NEW YORK, July 18, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Insulet Corporation (NASDAQ: PODD) between February 21, 2025 and May 26, 2026, inclusive (the "Class Period"), of the important August 31, 2026 lead plaintiff...
As active adults look for simple ways to support joint comfort, flexibility, and everyday mobility in 2026, this JointVance review examines the brand-stated turmeric and BioPerine® formula, once-daily convenience, current bundle pricing, and the key details buyers are comparing before ordering.
NEW YORK, July 18, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminders purchasers of common stock of GRAIL, Inc. (NASDAQ: GRAL) between May 13, 2025 and February 19, 2026, inclusive (the "Class Period"). A class action lawsuit has already been filed. If you...
NEW YORK, July 18, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Veritone, Inc. (NASDAQ: VERI) between October 14, 2025 and April 14, 2026, inclusive (the "Class Period"), of the important July 20, 2026 lead plaintiff...
New recommendations reinforce the evolution of ALARA and validate a new era of occupational wellness in fluoroscopy-guided medicine CHARLESTON, S.C. , July 18, 2026 /PRNewswire/ -- Salus Scientific welcomed the publication this week of a landmark multi-society expert consensus statement...